ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 22 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is 10.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,082 | -39.2% | 65,000 | 0.0% | 0.00% | -60.0% |
| Q2 2023 | $171,146 | -24.1% | 65,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $225,477 | +18.7% | 65,000 | +30.0% | 0.01% | +20.0% |
| Q4 2022 | $190,000 | -10.0% | 50,000 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $211,000 | -5.4% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $223,000 | -20.1% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $279,000 | +13.0% | 50,000 | +16.3% | 0.01% | +20.0% |
| Q4 2021 | $247,000 | -30.0% | 43,000 | +22.9% | 0.01% | -37.5% |
| Q3 2021 | $353,000 | +60.5% | 35,000 | +40.0% | 0.01% | +60.0% |
| Q2 2021 | $220,000 | -17.6% | 25,000 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $267,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $68,000 | 0.10% |
| Susquehanna International Group Ltd. | 22,002 | $98,000 | 0.02% |
| ARK Investment Management | 331,001 | $1,658,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 50,000 | $223,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $59,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,215 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,373 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,884 | $13,000 | 0.00% |